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Abstract 
IGH rearrangements are a common chromosomal 
abnormality seen in lymphoproliferative disorders, 
including ALL. Numerous translocation partners of 
IGH gene have been identified. Here we report a B-
ALL case with a t(14;17)(q32;q21) IGH/IGF2BP1. 
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Disease 
B-cell acute lymphoblastic leukemia (ALL) 
Phenotype/cell stem origin 
CD10+, CD19+, CD38+, cytoplastic CD22+ ALL 
Epidemiology 
Only one case, a 16 year old boy (Gu et al., 2014) 
Clinics 
Severe pancytopenia and an elevated lactate 
dehydrogenase (1048U/L); WBC was 2.7 X 10 9 




An additional copy of the derivative 14 was found 







IGF2BP1 is a member of Insulin-like growth factor 
2 mRNA-binding protein family; pro-oncogenic 
RNA-binding; post-transcriptional regulation of 
gene expression (Bell et al., 2013; Lederer et al., 
2014). 
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likely head-to-head fusion of IGF2BP1 with the IGH 
locus. 
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Fusion protein 
Oncogenesis 
Overexpression of the IGF2BP1 gene. 
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